Vita Life Sciences announced the following guidance for the Full Year ending 31 Dec. 2023: Sales: AUD 73.0 million-AUD 74.0 million (fiscal year 2022: AUD 66.9 million). Pre-tax Profit: AUD 11.3 million-11.8 million (fiscal year 2022: AUD 10.7 million).

Group sales growth continued in all major markets: Australia, Malaysia and exports into China. The profit increased on the back of higher sales and a non-operational gain from the revaluation of facilities of AUD 0.3 million.